Cerity Partners
ANGO icon

Cerity Partners’s AngioDynamics ANGO Stock Holding History

Cerity Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
18,464
+1,607
+10% +$18.3K ﹤0.01% 2946
2026
Q1 		$192K Buy
16,857
+2,547
+18% +$27.6K ﹤0.01% 2894
2025
Q4 		$184K Buy
14,310
+2,813
+24% +$34.7K ﹤0.01% 2654
2025
Q3 		$128K Sell
11,497
-862
-7% -$8.32K ﹤0.01% 2591
2025
Q2 		$123K Sell
12,359
-570
-4% -$5.58K ﹤0.01% 2448
2025
Q1 		$121K Buy
12,929
+2,333
+22% +$24.5K ﹤0.01% 2300
2024
Q4 		$87K Sell
10,596
-12,266
-54% -$90.2K ﹤0.01% 2349
2024
Q3 		$178K Buy
+22,862
New +$165K ﹤0.01% 2343
2024
Q2 		– Sell
-13,526
Closed -$79.4K – 2234
2024
Q1 		$79.4K Buy
+13,526
New +$80.4K ﹤0.01% 2224

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's ANGO Position: Q2 2026 in Review

Cerity Partners increased its AngioDynamics (ANGO) stake by 9.5% in Q2 2026, buying an estimated $18.3K and bringing the position to 18,464 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Cerity Partners first reported a position in ANGO in Q1 2024 and has held it in 9 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Cerity Partners held 18,464 shares of AngioDynamics worth $240K as of Q2 2026.
  • Cerity Partners bought 1,607 AngioDynamics shares in Q2 2026, an estimated $18.3K.
  • AngioDynamics made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2946 holding.
  • Cerity Partners first reported a position in AngioDynamics in Q1 2024 and has held it in 9 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.